title: Mercury poisoning associated with high-dose hepatitis-B immune globulin administration after liver transplantation for chronic hepatitis B.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA. Lowell@wudos2.wustl.edu
authors.forename: J A
authors.initials: JA
authors.lastname: Lowell
authors.forename: S
authors.initials: S
authors.lastname: Burgess
authors.forename: S
authors.initials: S
authors.lastname: Shenoy
authors.forename: J A
authors.initials: JA
authors.lastname: Curci
authors.forename: M
authors.initials: M
authors.lastname: Peters
authors.forename: T K
authors.initials: TK
authors.lastname: Howard
mesh_terms: D000328:Adult; D002614:Chelating Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000517:prevention & control; D019694:Hepatitis B, Chronic / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000009:adverse effects*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008630:Mercury Poisoning / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
chemical_list: D002614:Chelating Agents; D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin